Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+568.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+568.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
298.4x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 1280.45% |
| Q3 2025 | 107.86% |
| Q2 2025 | -3208.21% |
| Q1 2025 | -143.50% |
| Q4 2024 | 537.14% |
| Q3 2024 | -169.07% |
| Q2 2024 | -176.41% |
| Q1 2024 | -89.00% |
| Q4 2023 | 35.55% |
| Q3 2023 | 112.68% |
| Q2 2023 | -65.63% |
| Q1 2023 | -46.37% |
| Q4 2022 | 4.29% |
| Q3 2022 | 8.66% |
| Q2 2022 | 29.68% |
| Q1 2022 | -20.71% |
| Q4 2021 | 3.16% |
| Q3 2021 | 8.84% |
| Q2 2021 | 68.83% |
| Q1 2021 | -41.66% |
| Q4 2020 | -8.51% |
| Q3 2020 | 308.68% |
| Q2 2020 | -48.05% |
| Q1 2020 | -24.88% |
| Q4 2019 | 275.26% |
| Q3 2019 | -144.79% |
| Q2 2019 | 42.25% |
| Q1 2019 | -5.28% |
| Q4 2018 | 44.06% |
| Q3 2018 | -14.32% |
| Q2 2018 | 8.03% |
| Q1 2018 | 254.38% |
| Q4 2017 | -32.17% |
| Q3 2017 | -37.34% |
| Q2 2017 | 70.55% |
| Q1 2017 | -75.57% |
| Q4 2016 | 35.47% |
| Q3 2016 | 34.49% |
| Q2 2016 | 1.17% |
| Q1 2016 | -7.87% |